ReviewJACC. CardioOncology2026
Heart Substructure Radiation Dose and Cardiac Outcomes: Contemporary Evidence and Actionable Opportunities: JACC CardioOncology State-of-the-Art Review.
Review in JACC. CardioOncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contemporary cardiac outcomes research demonstrates that radiation dose to discrete cardiac substructures, particularly the coronary arteries, left ventricle, and pulmonary veins, strongly predict ischemia, heart failure, and arrhythmia endpoints, respectively, compared to whole heart metrics. This rapidly expanding literature has produced an increasingly rich but heterogeneous evidence base, underscoring both substantial progress and a persistent gap in clinical implementation. Importantly, current cardio-oncology guidelines and expert panel statements offer comprehensive cardiovascular recommendations, but integration of cardiac radiation dose exposure thresholds that translate into actionable clinical guidance remains limited. This partial alignment between emerging evidence and formal guidance contributes to uncertainty in clinical adoption and is further compounded by workflow complexity, limited consensus, and sparse clinical trial integration. In this State-of-the-Art Review, we synthesize contemporary cardiac dosimetry evidence on cardiac outcomes, propose a pragmatic, clinically-oriented framework, and outline actionable strategies to shorten the evidence-to-practice gap in the modern radiotherapy care continuum.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.